Logo
I

Inbiose

52 employees

“Dedicated to specialty carbohydrates for human health and beyond” Inbiose is dedicated to improving human health by making specialty oligosaccharides available for mainstream use. We strive to make available to the consumer the health benefits these complex sugars can bring to human and infant health, as well as specialized nutrition, cosmetics and beyond. Inbiose is a leading company in the development of Human Milk Oligosaccharides, which are of paramount importance for the health of newborns and developing infants. Our competences lie in the rapid development and cost-effective production of innovative specialty carbohydrates otherwise unavailable to society at large. Our development pipeline allows us to offer a high-throughput development platform, as well as process development, scale-up and regulatory services that compressing new product development cycles and minimizes time to market.

Investor insights

Funding rounds participated in

$18M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2013

Funding rounds raised

Total raised

$18M

from 1 investors over 1 rounds

I

Inbiose raised $18M on August 14, 2021

Investors: European Investment Bank

FAQ